PREDNISOLONE CLEARANCE - A POSSIBLE DETERMINANT FOR GLUCOCORTICOID EFFICACY IN PATIENTS WITH ORAL VESICULO-EROSIVE DISEASES

被引：11

作者：

LOZADA, F

FREY, FJ

BENET, LZ

机构：

[1] UNIV CALIF SAN FRANCISCO,SCH MED,DEPT MED,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94143

[2] UNIV CALIF SAN FRANCISCO,SCH PHARM,DEPT PHARM,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF DENTAL RESEARCH | 1983年 / 62卷 / 05期

关键词：

D O I：

10.1177/00220345830620051401

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

引用

页码：575 / 577

页数：3

共 18 条

[1] NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].

BENET, LZ ;

GALEAZZI, RL .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074

[2] SUCCESSFUL USE OF CYCLOPHOSPHAMIDE AND PREDNISONE FOR INITIAL TREATMENT OF PEMPHIGUS VULGARIS [J].

FELLNER, MJ ;

KATZ, JM ;

MCCABE, JB .

ARCHIVES OF DERMATOLOGY, 1978, 114 (06) :889-894

[3]

FREY FJ, 1980, J PHARMACOL EXP THER, V215, P287

[4] A SINGLE DOSE OF AZATHIOPRINE DOES NOT AFFECT THE PHARMACOKINETICS OF PREDNISOLONE FOLLOWING ORAL PREDNISONE [J].

FREY, FJ ;

LOZADA, F ;

GUENTERT, T ;

FREY, BM .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (03) :209-212

[5]

FREY FJ, 1979, CLIN CHEM, V25, P1944

[6]

GIBALDI M, 1975, PHARMACOKINETICS, P293

[7] IMMUNOFLUORESCENT STUDIES IN MUCOUS-MEMBRANE PEMPHIGOID [J].

GRIFFITH, MR ;

FUKUYAMA, K ;

TUFFANELLI, D ;

SILVERMAN, S .

ARCHIVES OF DERMATOLOGY, 1974, 109 (02) :195-199

[8]

JUSKO WJ, 1976, EFFECT DISEASE STATE, P99

[9] DECREASED CLEARANCE OF PREDNISOLONE, A FACTOR IN DEVELOPMENT OF CORTICOSTEROID SIDE-EFFECTS [J].

KOZOWER, M ;

VEATCH, L ;

KAPLAN, MM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1974, 38 (03) :407-412

[10]

LEVY G, 1964, AM J HOSP PHARM, V21, P402

← 1 2 →